Related Experiment Video
Updated: Jul 17, 2026

04:18
Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
Published on: October 10, 2025
EPICure: facts and figures: why preterm labour should be treated
1Academic Unit for Child Health, Queen Mary's School of Medicine and Dentistry, University of London, Homerton University Hospital, London, UK. Kate.Costeloe@homerton.nhs.uk
BJOG : an International Journal of Obstetrics and Gynaecology
|January 9, 2007
Summary
Extremely preterm birth survivors face significant long-term challenges, including cerebral palsy and cognitive impairment. Perinatal factors, such as antenatal steroids, play a critical role in determining outcomes for these vulnerable infants.
Area of Science:
- Neonatalogy
- Developmental Pediatrics
- Public Health
Background:
- Extremely preterm birth (before 26 weeks gestation) presents significant short- and long-term risks.
- The EPICure studies aimed to comprehensively assess outcomes for this high-risk population.
Purpose of the Study:
- To determine the short- and long-term outcomes of infants born extremely preterm.
- To identify perinatal factors influencing survival and neurodevelopmental outcomes.
Main Methods:
- Prospective data collection on all births before 26 weeks gestation in the UK and Republic of Ireland in 1995.
- Follow-up assessments at 2.5 and 6 years, including neurological examinations and cognitive testing (IQ, MDI).
- Statistical analysis, including logistic regression, to identify predictors of adverse outcomes.
Main Results:
- Survival rate was 39% (314/811) for infants admitted to neonatal units.
- At 6 years, 13% had disabling cerebral palsy and 13% had severe sensory impairment.
- Cognitive impairment was common, with a mean IQ of 82; 21% had IQs >3 SD below the comparator group.
Conclusions:
- Perinatal factors, including antenatal steroid use and mode of delivery, significantly impact outcomes.
- Abnormal head scan findings predict motor disability, while postnatal transfer is associated with motor disability.
- Improved survival since 1995 is noted, but the impact on severe adverse outcomes requires further investigation with new cohorts.
